Cytosorbents CTSO
NASDAQ CTSO
$4.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cytosorbents (CTSO) Amortization of Deferred Charges (2016)

Updated

Cytosorbents' Amortization of Deferred Charges was $97,041 in FY2018, up 18.3% from $82,054 in FY2017.

Analysis

Cytosorbents (CTSO) Amortization of Deferred Charges (2016) Analysis & Trends

  • Per Business Quant data, Amortization of Deferred Charges in earlier years was $82,054 in FY2017 (+169.2%) and $30,480 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Cytosorbents 12.73 Mn -10.29 Mn 7.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 15,240.00
API Access

Cytosorbents Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CTSO&period=max&api_key=YOUR_API_KEY